Risk factors of fracture following curettage for bone giant cell tumors of the extremities

Table 2 Details of 10 patients with postoperative fracture

Case	Sex	Age	Site	Campanacci classification	Pathological fracture at presentation	Denosumab administration	Previous surgery	Surgery	Local adjuvant therapy	Time to fracture (months)	Treatment for postoperative fracture	Local recurrence	Follow-up period (months)
1	M	29	Distal femur	Stage II	No	No	No	PMMA bone cement alone	Phenol	4	Resection and reconstruction with a hemicortical bone allograft	No	76
2	F	21	Distal femur	Stage II	No	No	No	PMMA bone cement alone	Phenol	15	Cement removal, filling of allografts bone chips, and osteosynthesis with a plate	No	80
3	M	61	Distal femur	Stage II	Yes	No	No	PMMA bone cement alone	Phenol	1	Osteosynthesis with a plate	No	57
4	F	32	Proximal tibia	Stage II	No	No	Yes	PMMA bone cement alone	Phenol	42	A screw fixation for a detachment fracture of tibial tuberosity	No	99
5	F	29	Distal femur	Stage II	No	No	No	PMMA bone cement alone	Phenol	6	Resection and reconstruction with a prosthesis	No	74
6	F	29	Distal femur	Stage II	No	No	No	PMMA bone cement alone	Phenol	2	Cement removal, filling of allografts bone chips, and osteosynthesis with a plate	No	25
7	M	29	Distal femur	Stage II	No	No	No	PMMA bone cement alone	None	6	Resection and reconstruction with a hemicortical bone allograft	No	93
8	M	35	Distal femur	Stage III	No	No	No	PMMA bone cement and allograft bone grafting	Phenol	3	Resection and reconstruction with a prosthesis	No	51
9	F	67	Distal femur	Stage II	Yes	Yes	No	PMMA bone cement alone	None	3	Radiofrequency ablation and percutaneous cementation for local recurrence and fracture	Yes	40
10	F	30	Distal femur	Stage II	No	No	No	PMMA bone cement alone	Cryosurgery	1	Osteosynthesis with a plate	No	44

ISSN: 1471-2474